← All ETFs

iShares U.S. Healthcare ETF

IYHHoldings as of July 31, 2026 (filed Sep 23, 2026)Form N-PORT on SEC EDGAR ↗

27% in rough estimates

Value per share

$42.95

if its companies were priced at our values from their reports

Last close

$78.95

Nov 13, 2026

83.8% above its value value

69 of 103 holdings valued90% of the fund

If the companies in IYH were priced at the values we work out from their own financial reports, one share would be worth about $42.95. It last closed at $78.95. Read the other way, that is the same gap: the value is 45.6% below the price.

What the fund holds

5% priced below value 85% priced above value10% not valued

27% of the fund is in companies with a rough estimate (marked ! below).

What moves the number

How IYH gets from its last close of $78.95 to its value of $42.95. Each bar starts where the previous one ends. A company priced above its value pulls the number down; one priced below it pushes the number up. Holdings we do not value leave it where it is.

  1. Last close$78.95
  2. Eli Lilly & Co−$10.59
  3. Johnson & Johnson−$5.10
  4. AbbVie Inc.−$3.15
  5. Merck & Co., Inc.−$2.17
  6. Thermo Fisher Scientific Inc.−$2.17
  7. All other holdings−$12.82
  8. Value per share$42.95

The steps add up to the $36.00 gap between the last close and the value.

Largest holdings

Showing 10 of 103 holdings.

CompanyShare of fundLast closeFair valueGapEffect
Eli Lilly & CoLLY Rough estimate
16.6%$1,445$276.68 422.2% above−$10.59
9.9%$285.96$99.76 186.7% above−$5.10
AbbVie Inc.ABBV
7.5%$295.00$138.09 113.6% above−$3.15
5.3%$407.52$374.54 8.8% above−$0.34
5.3%$147.76$70.51 109.6% above−$2.17
3.7%$700.18$187.16 274.1% above−$2.17
Amgen IncAMGN
3.6%$465.55$357.36 30.3% above−$0.66
3.0%$168.04$97.44 72.5% above−$1.00
Abbott LaboratoriesABT Rough estimate
2.7%$108.51$40.83 165.8% above−$1.33
Pfizer IncPFE · Not valued: too few usable years of reports
2.4%$28.90–––
Intuitive Surgical IncISRG Rough estimate
2.2%$443.47$176.06 151.9% above−$1.07
Danaher CorpDHR Rough estimate
2.1%$232.99$44.62 422.1% above−$1.35
2.0%$538.54$246.11 118.8% above−$0.84
1.9%$102.86$48.86 110.5% above−$0.79
1.9%$63.42$67.67 6.3% below+$0.10
1.5%$309.64$146.54 111.3% above−$0.64
1.4%$955.65$527.63 81.1% above−$0.49
1.3%$429.63$609.12 29.5% below+$0.44
Cigna GroupCI · Not valued: too few usable years of reports
1.1%$297.01–––
1.1%$498.88$366.05 36.3% above−$0.23
Boston Scientific CorpBSX Rough estimate
0.9%$44.35$29.34 51.2% above−$0.25
0.9%$218.05$138.46 57.5% above−$0.26
0.9%$107.19$49.08 118.4% above−$0.38
0.8%$704.46$184.66 281.5% above−$0.47
Humana IncHUM Rough estimate
0.8%$450.47$785.38 42.6% below+$0.46
0.7%$173.91$33.24 423.2% above−$0.45
BLACKROCK CASH FUNDS INSTITUTIONAL FUND SL AGENCYCash collateral for shares the fund lent out; it is owed back
0.7%––––
Waters CorpWAT · Not valued: too few usable years of reports
0.7%$460.58–––
0.6%$301.68$154.22 95.6% above−$0.25
0.6%$265.03$112.81 134.9% above−$0.29
Natera, Inc.NTRA · Not valued: not steadily profitable
0.6%$319.32–––
0.5%$83.05$48.77 70.3% above−$0.18
Biogen Inc.BIIB
0.5%$253.51$75.06 237.8% above−$0.30
0.5%$83.82$62.83 33.4% above−$0.10
Centene CorpCNC Rough estimate
0.5%$71.28$221.02 67.7% below+$0.84
0.5%$239.53$144.44 65.8% above−$0.16
Revolution Medicines, Inc.RVMD · Not valued: too few usable years of reports
0.5%$172.28–––
Dexcom IncDXCM Rough estimate
0.5%$83.28$27.42 203.7% above−$0.24
0.5%$207.11$54.67 278.9% above−$0.26
0.4%$370.64$231.75 59.9% above−$0.13
0.4%$416.50$100.16 315.8% above−$0.25
Royalty Pharma plcRPRX · Not valued: too few usable years of reports
0.4%$69.31–––
0.4%$259.39$131.21 97.7% above−$0.16
Insmed IncINSM · Not valued: too few usable years of reports
0.4%$121.14–––
0.4%$264.36$109.40 141.6% above−$0.17
0.4%$286.32$134.89 112.3% above−$0.15
0.4%$590.62$362.73 62.8% above−$0.11
Viatris IncVTRS
0.3%$20.84$13.57 53.6% above−$0.10
Alnylam Pharmaceuticals, Inc.ALNY · Not valued: not steadily profitable
0.3%$165.02–––
Incyte CorpINCY · Not valued: too few usable years of reports
0.3%$120.96–––
0.3%$103.22$84.75 21.8% above−$0.04
Moderna, Inc.MRNA · Not valued: too few usable years of reports
0.3%$223.22–––
Roivant Sciences Ltd.ROIV · Not valued: too few usable years of reports
0.3%$39.52–––
GUARDANT HEALTH INCGH · Not valued: not on our list of companies
0.3%$151.81–––
Medline Inc.MDLN · Not valued: too few usable years of reports
0.3%$39.44–––
0.2%$154.54$24.27 536.9% above−$0.17
0.2%$68.99$36.55 88.8% above−$0.09
0.2%$338.01$74.83 351.7% above−$0.15
0.2%$167.34$99.27 68.6% above−$0.08
0.2%$653.77$377.56 73.2% above−$0.07

Share of fund: how much of the fund is in the company. Gap: the company's last close compared with the value we work out from its reports. Effect: how much the company moves the value of one IYH share. Rough estimate (!): our value is far from the market price, probably because the reports miss something, like fast growth. We still use it. Not valued: we do not put a number on the company; it counts at its market price, so it does not move the value.

How we got this number

  1. Look insideWe read the fund's latest holdings report to the SEC, for July 31, 2026. It lists 103 holdings.
  2. Value each companyFor each company we value, we use the value we work out from its own financial reports instead of its stock price. That covers 69 of the holdings, 90% of the fund.
  3. Add it back upEverything else (cash, bonds and companies we do not value) stays at its market price. Added back up and split per share, one IYH share comes to $42.95.

Good to know

Technical details

The formula: value per share = last close × (1 + the sum over valued holdings of share of fund × (value ÷ last close − 1)). Each holding's share of the fund is measured against the fund's net assets at today's closes. Cash the fund holds as collateral for shares it has lent out is listed in its report but is owed back, so it does not count toward the fund's size.

Net assets, all share classes, Jul 31, 2026
$3.6B
Net assets at today's closes
$4.1B
Holdings in the report
103
Matched to a ticker
99
Valued
69
Short positions and derivatives
0.01% of net assets
Price against value
+83.8%
Value against last close
-45.6%
SEC series
S000004324
Filing (accession)
0001004726-26-008874

Delayed quote

Delayed price and chart from TradingView. This site does not receive or store these prices, and the value per share above does not use them. Showing the chart sends TradingView this page's address, the widget type, the ticker and your IP address, and TradingView may collect analytics; see Privacy.

Open on Yahoo Finance ↗

Sources. Holdings: SEC Form N-PORT for the period ended July 31, 2026 (accession 0001004726-26-008874). Company values: this site's filings-based values (Nov 14, 2026). Closing prices: IEX Historical Data (Nov 13, 2026).